Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/02/18 Updated
Market Cap: $35.6B (¥5.5T)
Stock Price: $19.21 (¥2,951)
Exchange Rate: 1 USD = ¥153.61

Notice Regarding the Status of Treasury Stock Acquisition

During the period from August 1, 2025 to August 31, 2025, no treasury stock was acquired, and the total acquisition price was 0 yen.

Importance:
Page Updated: January 22, 2026
IR Disclosure Date: September 1, 2025

Key Figures

  • Total Number of Shares Acquired: 0 shares (August 1, 2025 – August 31, 2025)
  • Total Acquisition Price of Shares: 0 yen (August 1, 2025 – August 31, 2025)
  • Maximum Number of Shares to Acquire: 80 million shares (per Board of Directors resolution)

AI要約

Overview of Treasury Stock Acquisition Status

Daiichi Sankyo Company, Limited conducted treasury stock acquisition based on the provisions of Article 165, Paragraph 2 of the Companies Act during the period from August 1, 2025 to August 31, 2025; however, no shares were acquired and the total acquisition price was 0 yen during this period. The method of acquisition was market purchase on the Tokyo Stock Exchange.

Future Policy

As a result of comprehensive consideration including stock price levels, no acquisition was conducted during the period; however, the Company intends to flexibly execute purchases when it judges the conditions to be suitable. Furthermore, pursuant to the Board of Directors resolution dated April 25, 2025, the upper limit for acquisition is 80 million shares, the maximum acquisition price is 200 billion yen, and the acquisition period is from May 1, 2025 to March 24, 2026.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.